Cargando…
Patient‐Derived Organoids from Colorectal Cancer with Paired Liver Metastasis Reveal Tumor Heterogeneity and Predict Response to Chemotherapy
There is no effective method to predict chemotherapy response and postoperative prognosis of colorectal cancer liver metastasis (CRLM) patients. Patient‐derived organoid (PDO) has become an important preclinical model. Herein, a living biobank with 50 CRLM organoids derived from primary tumors and p...
Autores principales: | Mo, Shaobo, Tang, Peiyuan, Luo, Wenqin, Zhang, Long, Li, Yaqi, Hu, Xiang, Ma, Xiaoji, Chen, Yikuan, Bao, Yichao, He, Xingfeng, Fu, Guoxiang, Xu, Xiaoya, Rao, Xinxin, Li, Xiaomeng, Guan, Ruoyu, Chen, Shengzhi, Deng, Yun, Lv, Tao, Mu, Peiyuan, Zheng, Qiang, Wang, Simin, Liu, Fangqi, Li, Yiwei, Sheng, Weiqi, Huang, Dan, Hu, Chen, Gao, Jianjun, Zhang, Zhen, Cai, Sanjun, Clevers, Hans, Peng, Junjie, Hua, Guoqiang |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley and Sons Inc.
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9631073/ https://www.ncbi.nlm.nih.gov/pubmed/36058001 http://dx.doi.org/10.1002/advs.202204097 |
Ejemplares similares
-
Assay establishment and validation of a high-throughput organoid-based drug screening platform
por: Li, Xiaomeng, et al.
Publicado: (2022) -
The pattern and treatment outcomes for rectal cancer with concurrent locoregional recurrence and distant metastases after total mesorectal excision
por: Chen, Yikuan, et al.
Publicado: (2022) -
Organoid based personalized medicine: from bench to bedside
por: Li, Yaqi, et al.
Publicado: (2020) -
Patient-derived organoids as a platform for drug screening in metastatic colorectal cancer
por: He, Xingfeng, et al.
Publicado: (2023) -
The genomic and transcriptomic landscapes of clock genes reveal the significance of circadian rhythm in the progression and immune microenvironment of metastatic colorectal cancer
por: Zhang, Long, et al.
Publicado: (2022)